PRODROMAL SCHIZOPHRENIA
Clinical trials for PRODROMAL SCHIZOPHRENIA explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL SCHIZOPHRENIA trials appear
Sign up with your email to follow new studies for PRODROMAL SCHIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a brain booster stop schizophrenia before it starts?
Disease control Recruiting nowThis study tests whether a drug that boosts NMDA receptors can help people with early signs of schizophrenia. It includes 48 adults who have mild symptoms but not full psychosis. The goal is to see if the drug reduces these early symptoms over 12 weeks.
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Could an antioxidant help prevent schizophrenia?
Symptom relief Recruiting nowThis study tests whether N-acetylcysteine (NAC), a safe antioxidant supplement, can reduce early psychosis-like symptoms in 90 people at clinical high risk for schizophrenia. Participants take NAC or a placebo for 8 weeks, and researchers measure changes in symptoms and brain act…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC
-
Brain training may lower psychosis risk in at-risk teens
Knowledge-focused Recruiting nowThis study tests a 10-week, at-home computer program called SCORES that uses brain exercises and group support to help teens at high risk for psychosis think faster and connect better with others. Researchers want to see if improving processing speed can boost social functioning …
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC